CClinicalTrials.gg
CompletedNCT01049269Updated Jun 25, 2015

Validation and Evaluation of a Portable Body Scanner for Determination of Obesity

An observational study in Obesity, sponsored by University of Texas at Austin. Completed at 1 site in United States. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2015-06-25.

Sponsored by University of Texas at Austin · Observational

Study type
Observational
Enrollment
180
Ages
18 Years to 60 Years
Sex
All
01

Study summary

The objective of this study is to validate a portable 3D human body measurement system which will improve approaches in obesity assessment.

Read the detailed description

Obesity has become an epidemic in the United States. A new technique of three-dimensional (3 D) photonic scanning will be used to create and validate a portable instrument that rapidly assesses obesity in clinical and field settings. This new portable body scanner will be a safe and easy method to help determine the incidence and type of obesity.

02

Conditions studied

  • Obesity

Browse trials for

Keywords

  • Body Scanning
  • Body Fat
  • Body Volume
  • Obesity
  • No Conditions
03

In context

Obesity

6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.

This study's enrollment of 180 is above the median of 135 across 1,283 observational studies indexed under Obesity.

Browse Obesity studies →

Lead sponsor

University of Texas at Austin is the lead sponsor of 319 studies on the registry; 78 are open to participants now.

Of its 10 completed or terminated interventional studies of FDA-regulated products, 5 (50%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Subject will be 18-60 years old, BMI 18.50 to 39.99 kg/m3, and free of known diseases, who are Hispanic and Not Hispanic or Latino Whites.

Inclusion criteria

  • 18-60 years old
  • BMI between 18.50 to 39.99 kg/m3
  • Free of known diseases
  • Hispanic and Not Hispanic or Latino Whites

Exclusion criteria

Exclusion Criteria:

  • Women who are pregnant, could be pregnant, or lactating
05

Study design

Enrollment
180 participants (actual)

Groups and cohorts

  • 1:one group
06

What researchers measure

Primary outcomes

  1. Body volume

    Time frame: 3 hours

Secondary outcomes

  1. Validating body imaging as an indicator of central obesity

    Time frame: 3 hours

07

Study locations

1 site
  • The Uniersity of Texas at Austin
    Austin, Texas 78712, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 25, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01049269
Lead sponsor
University of Texas at Austin
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Responsible party
Sponsor
First posted
Jan 14, 2010
Start date
Jan 2007
Primary completion
Jul 2013
Completion
Jul 2013
Last update
Jun 25, 2015

Study contacts

Jeanne H. Freeland-Graves, Ph.D.
principal investigator · The University of Texas at Austin

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2007. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion